Free Trial
CVE:CANX

CANEX Metals (CANX) Stock Price, News & Analysis

CANEX Metals logo
C$0.12 -0.01 (-4.17%)
As of 07/16/2025 09:30 AM Eastern

About CANEX Metals Stock (CVE:CANX)

Key Stats

Today's Range
C$0.12
C$0.12
50-Day Range
C$0.04
C$0.12
52-Week Range
C$0.03
C$0.12
Volume
500 shs
Average Volume
102,908 shs
Market Capitalization
C$14.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CANX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CANEX Metals and its competitors with MarketBeat's FREE daily newsletter.

CANX Stock News Headlines

CANEX Metals (CVE:CANX) Trading Up 50% - Time to Buy?
CANEX METALS INC (CANX.NE) - Yahoo Finance
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
CANEX Closes Equity Financing
CANEX Metals Increases Equity Financing
See More Headlines

CANX Stock Analysis - Frequently Asked Questions

CANEX Metals' stock was trading at C$0.04 on January 1st, 2025. Since then, CANX shares have increased by 187.5% and is now trading at C$0.12.

Shares of CANX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that CANEX Metals investors own include Myriad Genetics (MYGN), Acura Pharmaceuticals (ACUR), Akers Biosciences (AKER), Argos Therapeutics (ARGSQ), Bellerophon Therapeutics (BLPH), BioLineRx (BLRX) and Boundless Bio (BOLD).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Gold
Sub-Industry
N/A
Current Symbol
CVE:CANX
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.00
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$303.98 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-4.66%
Return on Assets
-3.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.42
Quick Ratio
15.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.03 per share
Price / Cash Flow
3.64
Book Value
C$0.05 per share
Price / Book
2.20

Miscellaneous

Outstanding Shares
122,414,000
Free Float
N/A
Market Cap
C$14.08 million
Optionable
Not Optionable
Beta
1.19
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (CVE:CANX) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners